RGC (Regencell Bioscience Holdings Limited Ordinary Shares) Stock Analysis - SEC Filings

Regencell Bioscience Holdings Limited Ordinary Shares (RGC) is a publicly traded Healthcare sector company. As of May 21, 2026, RGC trades at $27.39 with a market cap of $13.74B and a P/E ratio of 38.67. RGC moved +3.31% today. Year to date, RGC is +1.29%; over the trailing twelve months it is +131.52%. Its 52-week range spans $0.09 to $83.60. Rallies surfaces RGC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find RGC SEC filings?

Rallies organizes RGC SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

RGC Key Metrics

Key financial metrics for RGC
MetricValue
Price$27.39
Market Cap$13.74B
P/E Ratio38.67
EPS$0.72
Dividend Yield0.22%
52-Week High$83.60
52-Week Low$0.09
Volume90
Avg Volume0
Revenue (TTM)$3.16B
Net Income$112.30M
Gross Margin0.00%

Latest RGC News

Recent RGC Insider Trades

  • BELL THOMAS D JR bought 25.00K (~$369.00K) on Aug 29, 2017.
  • KAPLAN STEPHEN A bought 10.00K (~$148.70K) on Aug 25, 2017.
  • Ownby David bought 7.50K (~$105.30K) on Aug 24, 2017.

RGC Analyst Consensus

RGC analyst coverage data. Average price target: $0.00.

Common questions about RGC

Where can I find RGC SEC filings?
Rallies organizes RGC SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show RGC 10-K and 10-Q filings?
Rallies organizes RGC SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is RGC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RGC. It does not provide personalized investment advice.
RGC

RGC